Keyphrases
Gene Therapy
100%
Muscular Dystrophy
100%
Cell-based
50%
Clinical Trials
50%
Duchenne muscular Dystrophy
50%
Exon Skipping
50%
Most Common Form
25%
Current Treatment
25%
Skeletal muscle
25%
Effective Treatment
25%
High Efficiency
25%
Muscle Fiber
25%
Severe Disease
25%
Inherited Disorders
25%
Efficient Delivery
25%
Corrective
25%
RNA-based
25%
Cell Therapy
25%
Antisense
25%
Dystrophin
25%
Muscle Wasting
25%
Reading Frame
25%
Dystrophin Gene
25%
Gene Replacement
25%
Replacement Strategy
25%
Muscle Degeneration
25%
Progressive Weakness
25%
Gene Delivery
25%
Minigene
25%
Gene Modification
25%
Antisense Strategy
25%
Frame Reconstruction
25%
Systemic Gene Therapy
25%
Lentivirus
25%
Promising Treatment
25%
Modification Strategies
25%
Muscle Stem Cell (MuSC)
25%
Medicine and Dentistry
Gene Therapy
100%
Muscular Dystrophy
100%
Clinical Trial
66%
Ex Vivo
66%
Duchenne Muscular Dystrophy
66%
Antisense
66%
Exon Skipping
66%
Muscle Atrophy
66%
Dystrophin
66%
Gene Targeting
66%
Disease
33%
Cell Therapy
33%
Muscle Weakness
33%
Adeno-Associated Virus
33%
Reading Frame
33%
Cell Based Gene Therapy
33%
Lentivirus
33%
Muscle Stem Cell
33%
Skeletal Muscle
33%
Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
Clinical Trial
66%
Dystrophin
66%
Exon Skipping
66%
Gene Targeting
66%
Genetics
33%
RNA
33%
Stem Cell
33%
Skeletal Muscle
33%
Antisense
33%
Animal Model
33%
Reading Frame
33%
Minigene
33%
Antisense Strategy
33%
Lentivirus
33%
Neuroscience
Muscular Dystrophy
100%
In Vivo
40%
Exon Skipping
40%
Dystrophin
40%
Gene Delivery
40%
Skeletal Muscle
20%
Stem Cell
20%
Reading Frame
20%
Cell Therapy
20%
Adeno-Associated Virus
20%